FXYD3 Antibodies

Santa Cruz Biotechnology offers a broad range of FXYD3 monoclonal antibodies for research focused on understanding FXYD3 protein function. FXYD3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FXYD3, also known as the gamma subunit of the epithelial sodium channel, plays a critical role in regulating ion transport and maintaining cellular homeostasis. Its function is essential in processes such as epithelial sodium absorption and blood pressure regulation, making it a significant target for research in cardiovascular and renal physiology. Understanding FXYD3 mechanisms can provide insights into various pathophysiological conditions, including hypertension and edema. FXYD3 expression patterns and regulatory mechanisms continue to be active areas of investigation in both normal physiology and disease states. Researchers exploring FXYD3's role in ion channel regulation and cellular signaling pathways can utilize specific detection methods to track protein localization and interactions. Current studies are expanding knowledge of FXYD3's involvement in both physiological and pathological processes. Santa Cruz Biotechnology monoclonal antibodies targeting FXYD3 enable researchers to advance scientific understanding of ion transport regulation and its impact on human health.